Ausbiz interview: Peter Molloy discusses sales growth

  25 Feb 2025

Firebrick Pharma’s CEO and Executive Chair Peter Molloy highlights the commercial success of Nasodine Nasal Spray, a product targeting germs responsible for respiratory infections. The spray is gaining traction in multiple markets, including Singapore which has enabled rapid market entry without regulatory delays. Molloy explains how Singapore is acting as a springboard for entry into other markets across the region.